Supernus Pharmaceuticals, Inc.
(NASDAQ : SUPN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.24%165.220.7%$1347.13m
LLYEli Lilly & Co. 0.98%324.711.1%$1078.19m
ABBVAbbVie, Inc. 2.04%141.141.9%$869.64m
PFEPfizer Inc. 0.84%44.510.9%$804.85m
BMYBristol-Myers Squibb Co. 1.22%71.391.0%$782.09m
MRKMerck & Co., Inc. 0.78%88.230.7%$715.89m
AZNAstraZeneca Plc 2.40%56.891.0%$396.84m
ALNYAlnylam Pharmaceuticals, Inc. -0.77%195.278.2%$215.71m
GSKGSK Plc 2.29%30.940.3%$214.43m
NVSNovartis AG 2.22%78.380.2%$206.16m
GBTGlobal Blood Therapeutics, Inc. 0.01%68.495.4%$191.19m
IDXXIDEXX Laboratories, Inc. 3.67%349.033.9%$191.04m
HZNPHorizon Therapeutics Plc 1.73%65.375.4%$176.65m
ATXIAvenue Therapeutics, Inc. 20.16%13.830.0%$167.39m
SRPTSarepta Therapeutics, Inc. -0.84%109.0212.4%$135.59m

Company Profile

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.